Lyubov Zaitseva

Norwich Research Park
Norwich, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases.

Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: January 14, 2022

CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma.

CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma.

Journal: Cancer research
Published: March 12, 2018

PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts.

PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts.

Journal: Leukemia
Published: March 03, 2018

Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.

Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.

Journal: Leukemia
Published: November 08, 2017

Pulling the plug - halting cancer's theft of mitochondria.

Pulling the plug - halting cancer's theft of mitochondria.

Journal: Oncoscience
Published: October 25, 2017

NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.

NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.

Journal: Blood
Published: March 10, 2017

PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.

PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.

Journal: Blood cancer journal
Published: January 16, 2017

Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.

Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.

Journal: Blood
Published: August 18, 2016

Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.

Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.

Journal: Oncotarget
Published: October 06, 2015

Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.

Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.

Journal: Scientific reports
Published: March 18, 2015

Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma.

Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma.

Journal: Cell cycle (Georgetown, Tex.)
Published: January 08, 2015

Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells.

Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells.

Journal: The Lancet. Haematology
Published: December 16, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026